A LacZ-based transgenic mouse for detection of somatic gene repair events in vivo

Gene Therapy

Volumn 11, Issue 17, 2004, Pages 1351-1357

  Nickerson, H D ^a   Colledge, W H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

galactosidase; Gene repair; Rosa 26; Transgenic mouse

Indexed keywords

ADENOSINE; ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; GLUTAMIC ACID; GUANINE; LYSINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL TYPE; CHROMOSOME MUTATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC REGULATION; HEART; IN VIVO STUDY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SMOOTH MUSCLE; SOMATIC GENE THERAPY; SPLEEN; STEM CELL; TRANSGENIC MOUSE; ANIMAL; ANIMAL MODEL; CELL CULTURE; ELECTROPORATION; GENE THERAPY; GENETIC TRANSFECTION; LACTOSE OPERON; LIVER; METABOLISM; METHODOLOGY; WESTERN BLOTTING;

MUS MUSCULUS; ROSA;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPORATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; LAC OPERON; LIVER; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; STEM CELLS; TRANSFECTION;

EID: 4444335284     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302311     Document Type: Article

References (36)

1. Alexeev V, Yoon K. Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 1998; 16: 1343-1346.
2. Xiang Y et al. Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide. J Mol Med 1997; 75: 829-835.
3. Igoucheva O, Peritz AE, Levy D, Yoon K. A sequence-specific gene correction by an RNA-DNA oligonucleotide in mammalian cells characterized by transfection and nuclear extract using a lacZ shuttle system. Gene Therapy 1999; 6: 1960-1971.
4. Igoucheva O, Alexeev V, Yoon K. Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Therapy 2001; 8: 391-399.
5. Nickerson HD, Colledge WH. A comparison of gene repair strategies in cell culture using a lacZ reporter system. Gene Therapy 2003; 10: 1584-1591.
6. Lu IL et al. Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies. Gene Therapy 2003; 10: 1910-1916.
7. Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides (see comments). Nat Med 1998; 4: 285-290.
8. Kren BT et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci USA 1999; 96: 10349-10354.
9. Alexeev V et al. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide (see comments). Nat Biotechnol 2000; 18: 43-47.
10. Bartlett RJ et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA:DNA oligonucleotide. Nat Biotechnol 2000; 18: 615-622.
11. Goncz KK et al. Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Therapy 2001; 8: 961-965.
12. Kapsa R et al. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther 2001; 12: 629-642.
13. Tagalakis AD et al. Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J Biol Chem 2001; 276: 13226-13230.
14. Zambrowicz BP et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 1997; 94: 3789-3794.
15. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 1991; 5: 1513-1523.
16. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain (letter). Nat Genet 1999; 21: 70-71.
17. Mao X, Fujiwara Y, Orkin SH. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci USA 1999; 96: 5037-5042.
18. Awatramani R, Soriano P, Mai JJ, Dymecki S. An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nat Genet 2001; 29: 257-259.
19. Cupples CG, Cabrera M, Cruz C, Miller JH. A set of lacZ mutations in Escherichia coli that allow rapid detection of specific frameshift mutations. Genetics 1990; 125: 275-280.
20. Igoucheva O, Yoon K. Targeted single-base correction by RNA-DNA oligonucleotides. Hum Gene Ther 2000; 11: 2307-2312.
21. Pierce EA et al. Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Therapy 2003; 10: 24-33.
22. Cervantes RB et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002; 99: 3586-3590.
23. Dowty ME et al. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci USA 1995; 92: 4572-4576.
24. Hagstrom JE et al. Nuclear import of DNA in digitonin-permeabilized cells. J Cell Sci 1997; 110 (Part 18): 2323-2331.
25. Kohler SW et al. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen 1991; 18: 316-321.
26. Gossen JA et al. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA 1989; 86: 7971-7975.
27. Monroe JJ et al. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. Mutat Res 1998; 421: 121-136.
28. McMahon JM et al. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Therapy 1998; 5: 1283-1290.
29. Thorpe P, Stevenson BJ, Porteous DJ. Optimising gene repair strategies in cell culture. Gene Therapy 2002; 9: 700-702.
30. Alexeev V, Igoucheva O, Yoon K. Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Therapy 2002; 9: 1667-1675.
31. Gonzaez-Guerrico AM et al. Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J Biol Chem 2002; 277: 17239-17247.
32. Goncz KK et al. Application of SFHR to gene therapy of monogenic disorders. Gene Therapy 2002; 9: 691-694.
33. Scott ES, Wiseman JW, Evans MJ, Colledge WH. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med 2001; 3: 125-134.
34. Colosimo A et al. Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Mol Ther 2001; 3: 178-185.
35. Wiseman JW, Goddard CA, Colledge WH. Steroid hormone enhancement of gene delivery to a human airway epithelial cell line in vitro and mouse airways in vivo. Gene Therapy 2001; 8: 1562-1571.
36. Pitard B et al. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther 2002; 13: 1767-1775.